Results 131 to 140 of about 11,797 (221)

Impact of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine on sexually transmitted and reproductive tract infections: results from a randomized trial in Uganda. [PDF]

Int J Epidemiol
Adrama H, Dela Cruz EJ, Ozarslan N, Kakuru A, Odongo B, Gaw SL, Benjamin-Chung J, Kizza J, Aguti M, Ategeka J, Olwoch P, Nakalembe M, Opira B, Clark TD, Kamya MR, Rosenthal PJ, Dorsey G, Roh ME.   +17 more
europepmc   +1 more source

Trends in Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine and amodiaquine over ten years of seasonal malaria chemoprevention in Moissala Health District, Chad. [PDF]

Malar J
Grandesso F, Diar MSI, Kouassi F, Sayyad-Hilario J, Ouedraogo P, Djimde AA, Singh S, Dama S.   +7 more
europepmc   +1 more source

Evaluation of Performance Indicators for Malaria Control in Kinshasa from 2020 to 2023, the Democratic Republic of the Congo. [PDF]

Epidemiologia (Basel)
Lutumbu BB, Mbanzulu KM, Kapour GK, Ndona MM, Zanga J, Mukendi JPK, Kayembe H, Mbangama A, Wumba R.   +8 more
europepmc   +1 more source

The impact of sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive treatment for the prevention of malaria in pregnancy in Africa: an updated systematic review and meta-analysis. [PDF]

Lancet Infect Dis
van Eijk AM, Stepniewska K, Khairallah C, Rodriguez E, Ahn J, Gutman JR, Ter Kuile FO, IPTp-SP Effectiveness Study group.   +7 more
europepmc   +1 more source

Comparative effects of antimalarial drugs on oxidative phosphorylation, mitochondrial dynamics and mitophagy in <i>Plasmodium berghei</i>-infected mice. [PDF]

Toxicol Rep
Olanlokun JO, Yahaya OO, Babarinde CO, Oloke OM, Steenkamp P, Prinsloo G.   +5 more
europepmc   +1 more source

Knowledge, attitudes, practices, and future intentions to use intermittent preventive treatment with sulfadoxine-pyrimethamine among pregnant women in southern Ghana. [PDF]

BMC Pregnancy Childbirth
Aberese-Ako M, Ebelin W, Magnussen P, Norshie K, Klu D, Immurana M, Ampofo GD, Tagbor H.   +7 more
europepmc   +1 more source

Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a two-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus artesunate monotherapy among asymptomatic children 3-5 years of age in Zambia. [PDF]

BMC Infect Dis
Martinez-Vega R, Chaponda M, Mousa A, Gwasupika J, Chaponda EB, Daka V, Mwanza S, Chipunga M, Beshir KB, Chopo-Pizarro A, Kaur H, Okell L, Hansson H, Hocke EF, Alifrangis M, Gosling R, Roper C, Sutherland C, Chico RM.   +18 more
europepmc   +1 more source

Repurposing antimalarials: pyrimethamine exhibits superior in vitro activity to metronidazole against Gardnerella while sparing Lactobacillus. [PDF]

J Antimicrob Chemother
Rosca AS, Chaponda EB, Beckers T, De Koning HP, Chico RM, Cools P.   +5 more
europepmc   +1 more source

Effect of malaria chemoprevention for school-age children across transmission archetypes: a modelling study.

Lancet Glob Health
Suresh J, Zimmermann M, Maiteki C, Stahlfeld A, Pratt A, Mathanga DP, Staedke SG, Laufer MK, Drakeley C, Bever C, Cohee LM.   +10 more
europepmc   +1 more source

Border Region Surveillance of Malaria Drug Resistance, Northern Burundi, 2023-2024. [PDF]

Emerg Infect Dis
Niyomwungere D, Sinarinzi P, Caspar E, Thiebaut L, Strubel PE, Tibiri YNG, Ma L, Rurihafi J, Ndizeyimana P, Hakizimana P, Niyizompa N, Witonze A, Ndayiragije V, Ndayisenga F, Ndikumukiza M, Niyonkuru O, Niyonsaba JC, Bangirinama C, Bigirimana JL, Ntahondi N, Mugisha L, Nibakire M, Nzoyikorera N, Sinzinkayo D, Menard D, Nyandwi J.   +25 more
europepmc   +1 more source